Biogen | BIIB - 债务





债务 更改 日
AbbVie USD 67.5B 67.5B 2025-12
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
ALKERMES USD 71.6M 1.08M 2025-09
Amgen USD 54.59B 1.62B 2025-09
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Gilead Sciences USD 24.94B 5M 2025-12
Incyte USD 40.41M 855K 2025-12
Merck USD 41.37B 5.97B 2025-09
Moderna USD 734M 7M 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novartis USD 35.38B 2.74B 2025-12
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 2.71B 2.42B 2025-12
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 20.33B 1.43B 2025-12
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Teva Pharmaceutical Industries USD 17.09B 21M 2025-12
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09